Add BrightSurf on Google Email

The Lancet


Partner reduction is pivotal for HIV prevention

A new approach to HIV prevention focuses on reducing partners, with early evidence from Uganda and Kenya showing a decline in HIV incidence among men. The strategy is seen as a crucial step towards reversing the epidemic, particularly in regions where partner reduction has been successful.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 30, 2006

World Health Organization in the era of Margaret Chan

Margaret Chan takes over as WHO Director-General on January 4, 2007, with a daunting task of prioritizing programs amidst widespread failures in malaria, tuberculosis, HIV-AIDS, child mortality, and maternal health. The Lancet Editorial highlights her need to create an operational team that commands confidence from member states.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 16, 2006

Study shows survival benefit for anastrozole

A recent study published in The Lancet Oncology found that switching to anastrozole after 2-3 years of tamoxifen treatment significantly improves overall survival and reduces the risk of recurrence for postmenopausal women with hormone-sensitive early-stage breast cancer. The study analyzed data from three trials and used meta-analysis...

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateNov 16, 2006

Type 2 diabetes epidemic in Asia

The proportion of people with type 2 diabetes in Asia has increased rapidly, with younger age groups developing the condition and suffering longer from chronic complications. The region's healthcare systems are under threat as a result.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 9, 2006

First global study of sexual behavior

The first global analysis of sexual behavior data found that monogamy is the dominant pattern worldwide, and developed nations report high rates of multiple partnerships. Despite this, adolescents have high rates of unintended pregnancy, unsafe abortions, and STIs.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 31, 2006

Vaccine against pneumococcal disease

Researchers found a two- or three-dose schedule may be as effective as the traditional four-dose schedule in preventing pneumococcal disease in young children. The vaccine showed high effectiveness against seven strains of Streptococcus pneumoniae, with 96% efficacy in healthy children and 81% in those at risk.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 26, 2006